Health in Afghanistan

Tuberculosis is endemic in Afghanistan, with over 76,000 cases reported per year. The United States Agency for International Development is engaged in promulgating DOTS (directly observed therapy, short course) treatments, as well as TB awareness and prevention.[16]

BRAC is a development organisation that focuses on the alleviation of poverty through the empowerment of the poor to improve their lives. BRAC Afghanistan is involved in assisting Afghan Ministry of Public Health in the implementation of the Basic Package of Health Services (BPHS) in Kabul, Badghis, Balkh and Nimroz. This implementation is mainly funded by the World Bank and the USAID-REACH (United States Agency for International Development - Rural Expansion of Afghanistan Community-based Healthcare).

Tuberculosis is a serious public health problem in Afghanistan. In 2007, 8,200 people in the country died from tuberculosis and, in the WHO's Global Tuberculosis Control Report 2009, an annual estimated figure of 46,000 new cases of tuberculosis were in Afghanistan. As such, Afghanistan is ranked 22nd in amongst highly affected Tuberculosis countries.[17]

To help control tuberculosis, BRAC Afghanistan started the community-based TB DOTS under the Fund for Innovative DOTS Expansion through Local Initiatives to Stop TB (FIDELIS) project in 2006. In the first phase of this programme, diagnostic facilities for tuberculosis were expanded through the setting up of 50 TB microscopy centres. This phase lasted from January 2006 and up to March 2007. Over the next two years, facilities were further expanded and 92 more Tuberculosis Microscopy Centres were set up under the FIDELIS programme.[18]

The Tuberculosis Control Assistance Programme (TB CAP) is another project taken up between BRAC Afghanistan, World Health Organization (WHO) and Management Sciences for Health (MSH) in a bid to fight TB in Afghanistan. In this project, BRAC Afghanistan supports the BPHS (Basic Package of Health Services) project by replicating the CB-DOTS model into health systems of four provinces: Baghlan, Jawzjan, Badakshan and Herat. BRAC Afghanistan was selected as Principal Recipient (PR) for malaria and TB components of the Global Fund 8.[19]

In 2009, 2,143,354 patients received treatment under the health programs mentioned. As of August 2010, BRAC Afghanistan had covered 388 districts and 25 million of the total population are under the BRAC Afghanistan Health Program. Health facilities also include six District Hospitals, 26 Comprehensive Health Centres, 53 Basic Health Centres, 18 Sub Health Centres as well as 533 Mobile Clinics every month.[20]

The prevalence of HIV in Afghanistan is 0.04%.[6] According to Afghanistan's National Aids Control Program (NACP), 504 cases of HIV/AIDS were documented in late 2008.[21] By the end of 2012, the numbers reached 1,327. Afghanistan's healthy ministry stated that most of the HIV patients were among intravenous drug users and that 70% of them were men, 25% women, and the remaining 5% children. They belonged to Kabul, Kandahar and Herat, the provinces from where people make the most trips to neighboring or other foreign countries.[22] Regarding Kandahar, 22 cases were reported in 2012. AIDS Prevention department head Dr Hamayoun Rehman said 1,320 blood samples were examined and 21 were positive. Among the 21 patients, 18 were males and three were females who contracted the deadly virus from their husbands. He said four people had reached a critical stage while three had died. The main source of the disease was the use of syringes used by drug addicts.[23] There are approximately 23,000 addicts in the country who inject drugs into their bodies using syringes. As of 2015, as much as 6,900 people are living in Afghanistan with HIV and about 300 have died in from the disease.[6]

Afghanistan, Pakistan, and Nigeria remain the only countries where the transmission of endemic wild poliovirus type 1 (WPV1) continues.[25] Thirteen WPV1 cases were confirmed in Afghanistan in 2016, a decrease of seven from the 20 cases reported in 2015. From January to June 2017, five WPV1 cases were reported, compared with six during the same period in 2016. The number of affected districts declined from 23 (including WPV1-positive acute flaccid paralysis [AFP] cases and positive environmental sewage samples) in 2015 to six in 2016. To achieve WPV1 eradication, it is important that Afghanistan’s polio program continue to collaborate with that of neighboring Pakistan to track and vaccinate groups of high-risk mobile populations and strengthen efforts to reach children in security-compromised areas.[26] The Afghan Ministry of Public Health along with World Health Organization and UNICEF are engaged in a campaign to eliminate polio in the country. Wild poliovirus is present in Afghanistan, though in limited areas. Reported cases were on the decline, from 63 in 1999 to 17 in 2007, until increased violence in 2008 impeded vaccination efforts, causing cases to climb up for the first nine months of 2009. While most cases in 2014, 2015 and 2016 were due to poliovirus imported from neighbouring Pakistan, there is also ongoing transmission of virus within Afghanistan. The majority of cases were reported from Nangarhar province in eastern Afghanistan, which borders Pakistan, and were genetically linked to cases in Pakistan. Afghanistan reported 20 cases in 16 districts in 2015, compared with 28 cases in 19 districts in 2014, and 8 cases in 2016, The most recent case had onset of paralysis on 8 August/2016, from Kabul.

In Afghanistan, the mortality ratio for children <5 years of age is 90 deaths/1,000 live births, twice the global average; 20% of deaths are from pneumonia.[27] Although Afghanistan is considered 1 of the 5 countries with the highest level of childhood deaths from pneumonia, studies of the risk factors for death and etiology of pneumonia among children in Afghanistan are lacking.[28] The CFR for children <5 years of age with pneumonia admitted to a regional hospital in Afghanistan was 12.1%, compared with only 7.6% for the full WHO Eastern Mediterranean region. Most deaths occurred within 2 days of hospitalization. Factors that may have contributed to the high mortality rate were delays in presentation to healthcare facilities, inability to identify severe symptoms in children, and delayed referral from primary care.[29] These issues could be addressed by strengthening the Integrated Management of Childhood Illness program of WHO, introduced in Afghanistan in 2004.[30]

More than half of Afghan girls and boys suffer damage to their minds and bodies that cannot be undone because they are poorly nourished in the crucial first two years of life. High levels of Malnutrition in Children is rate of stunting 60.5%, One third of children (33.7%) underweight, Anaemia 50% in children 6–24 months, High iodine deficiency: 72%(school age) and also the high levels of Malnutrition in Women is Iron deficiency: 48.4%, non-pregnant and Iodine deficiency 75%.and high levels of chronic energy deficiency are 20.9% low BMI.

Supporting the Implementation of Nutrition (and Health)-Specific Interventions through BPHS and EPHS. The Ministry of Public Health, World Bank and WFP are working together for ensuring that mothers are healthy before they become pregnant and throughout pregnancy, promoting appropriate Infant and Young Child Feeding Practices, ensuring that children receive adequate health care to prevent growth faltering resulting from illness and early treatment of acute malnutrition and Promote appropriate hygiene practices.

Despite anti-leprosy initiatives by Leprosy Control (LEPCO) dating to 1984, leprosy is present in Afghanistan, with 231 cases reported in the 2001-2007 period. Just over three-quarters of the cases were the MB-type, with the rest PB-type. Leprosy has been reported in the central Hindu Kush mountain area of the country. Mainly in the provinces of Bamyan, Ghazni, Balkh.[31]

Being the 15th least developed country in the world, Afghanistan faces difficulties in sanitation. In urban areas 40% of the population have unimproved access to sanitation facilities. Because of this many Afghanistan natives are forced to combat typhoid fever. Typhoid fever is one of Afghanistan's major infectious diseases in terms of food/waterborne diseases. This infectious disease occurs when fecal material comes into contact with food or water. Symptoms vary from case to case but often mild fever is present and if left untreated death may occur.[6]

Sanitation issues place the Afghanistan population at risk of contracting hepatitis A through the consumption of food and water that has been contaminated by fecal material. Hepatitis A works by inhibiting the liver from functioning properly. Symptoms generally include jaundice, fatigue, loss of appetite, while some victims may experience diarrhea. Furthermore, symptoms will appear 2–6 weeks after an individual has come into contact with the hepatitis A virus.[6] Efforts have been made to fight hepatitis through efforts by the Pashtun community. Tribal leader Dawud Suleimankhel is credited with establishing an organization that teaches people about Hepatitis, Tuberculosis, and other diseases. Various aid organizations have also started to work in Afghanistan to combat Hepatitis.

Hepatitis C virus (HCV) is a blood-borne pathogen associated with several morbidities and mortality.[32] The state of the infection remains poorly understood in most MENA countries including Afghanistan. Here, the decades of political unrest and military conflicts, and the thriving opiates industry suggest a vulnerability for the transmission of blood-borne infections including HCV.[33] HCV prevalence in the population at large in Afghanistan appears to be around 1%. HCV prevalence among people who inject drugs is substantial with evidence of regional and temporal variation. HCV prevention efforts in Afghanistan should focus on expanding access to and coverage of harm reduction services among people who inject drugs and prisoners.[34] Adoption of the new World Health Organization guidelines for the use of safety-engineered syringes could also minimize exposure to HCV and other blood-borne pathogens.[35]

Leishmaniasis is estimated to cause the ninth largest disease burden among infectious diseases worldwide and it is not preventable by vaccination or chemoprophylaxis, but only by personal protective measures preventing bites of infectious arthropod vectors.[36] Four Leishmania species are considered endemic in northern Afghanistan, of which Leishmania tropica, L. major, and L. donovani can produce skin lesions while L. donovani and L. infantum visceralize.[37] Visceral leishmaniasis infections are often recognised by fever, swelling of the liver and spleen, and anemia. They are known by many local names, of which the most common is probably Kala azar.[38][39] A total of 21 cases of VL acquired in Afghanistan, all in the 1980s according to CDC reporting.[40]

In 2002, soon after the NATO-led overthrow of the Taliban regime, a survey of maternal mortality in Afghanistan was done, commissioned by the Afghan Ministry of Public Health, the US Centers for Disease Control and Prevention, and UNICEF. The results were published in The Lancet in 2005 and provided the woeful findings that, in a population of 90 816, 357 women of reproductive age died; 154 deaths were related to complications during pregnancy, childbirth, or the puerperal period. Most maternal deaths were caused by ante-partum haemorrhage, except in Ragh, where a greater proportion of women died of obstructed labour. All measures of maternal risk were high, especially in the more remote areas; the maternal mortality ratio (per 100 000 livebirths) was 418 (235–602) in Kabul, 774 (433–1115) in Alisheng, 2182 (1451–2913) in Maywand, and 6507 (5026–7988) in Ragh. In the two rural sites, no woman who died was assisted by a skilled birth attendant. The survey provided a clear illustration that Maternal mortality in Afghanistan is high and becomes significantly greater with increasing remoteness.[13]

Although Maternal Mortality is high in Afghanistan. It is on the path of improvement. Initially, having one of the highest maternal mortality rates in the world at 1640 per 100,000 in 1980 to 400 per 100,000 in 2013.[41]